Yale School of Medicine, Section Hematology
"There are many opportunities, spanning a wide breadth of clinical medicine, for those trained and experienced in classical hematology to contribute meaningfully to patient care. Being part of Yale’s Hematology-Focused Fellowship Training Program is an honor for me, and I very much look forward to bringing my enthusiasm for care and training in this medical discipline to curricular development, clinical oversight and mentorship for our new trainees."
Robert D. Bona, MD, ASH HFFTP Associate Program Director
Contact: [email protected]
"The creation of the ASH Hematology-Focused Fellowship Training Program is the culmination of a long journey, spurred by a multiyear study of the hematology workforce and sponsored by ASH, which actually had part of its roots at Yale. We’re thrilled to have the honor of participating in the ASH Hematology-Focused Fellowship Training Program Consortium and plan to draw upon our institution’s vast culture of innovation and collaboration in designing our interdisciplinary program. We aim to train fellows from diverse backgrounds who will redefine the scope, breadth, and reach of academic hematology, specifically in classical hematology, with the goal of advancing scientific discovery, growing and diversifying the workforce, and improving health equities and access to care for patients with classical hematologic diseases."
Alfred Ian Lee, MD, PhD, ASH HFFTP Program Director
Contact: [email protected]
The Yale School of Medicine has a rich history of innovations in classical hematology. For 50 years, Yale has been home to numerous landmark discoveries in hemoglobin and red cell disorders, hematopoiesis, platelet biology, and, more recently, COVID-19.
The Yale HFFTP will draw upon the diverse clinical and scholarly strengths of Yale and its numerous interdisciplinary programs to create an entirely novel curriculum with robust clinical training and unparalleled research opportunities in all aspects of classical hematology. The fellowship will provide broad exposure to a wealth of collaborative research programs, interdisciplinary pathways, and opportunities for advanced degree training.
Fellows in the Yale HFFTP will receive rigorous clinical training across a vast spectrum of hematologic diseases, including hemophilia, hemostatic and thrombotic disorders, sickle cell disease, red cell disorders, vascular malformations, hematologic malignancies, and rare diseases. A longitudinal curriculum in research methodology, numerous teaching conferences, and rotations in transfusion and laboratory medicine, molecular diagnostics, and genetics will complement the clinical training. The Yale HFFTP will aim to mentor classical hematology-focused fellows who will lead the field in both traditional and innovative scholarly pursuits, including basic and translational science, medical education, health equities research, and the promotion of diversity, equity, and inclusion.